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Abstract
The molecular mechanisms that drive the infection by the severe acute respira-
tory syndrome coronavirus 2 (SARS-CoV-2)—the causative agent of coronavirus
disease 2019 (COVID-19)—are under intense current scrutiny to understand how
the virus operates and to uncover ways in which the disease can be prevented or
alleviated. Recent proteomic screens of the interactions between viral and host
proteins have identified the human proteins targeted by SARS-CoV-2. The DNA
polymerase α (Pol α)–primase complex or primosome—responsible for initiating
DNA synthesis during genomic duplication—was identified as a target of non-
structural protein 1 (nsp1), a major virulence factor in the SARS-CoV-2 infection.
Here, we validate the published reports of the interaction of nsp1 with the
primosome by demonstrating direct binding with purified recombinant compo-
nents and providing a biochemical characterization of their interaction. Further-
more, we provide a structural basis for the interaction by elucidating the cryo-
electron microscopy structure of nsp1 bound to the primosome. Our findings pro-
vide biochemical evidence for the reported targeting of Pol α by the virulence fac-
tor nsp1 and suggest that SARS-CoV-2 interferes with Pol α's putative role in the
immune response during the viral infection.
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1 | INTRODUCTION
The enormous disruption to public health and the
global economy caused by COVID-19 has spurred
international research efforts to unravel the
molecular biology of SARS-CoV-2 in order to devise
effective means of therapeutic and prophylactic
intervention.
Coronaviruses comprise a large family of positive-sense
single-strand RNA viruses that cause respiratory and enteric
diseases in animals and humans.1–3 Seven coronaviruses
that are capable of infecting humans have been identified to
date, belonging to the genera alphacoronavirus (HCoV-229E
and HCoV-NL63) and betacoronavirus (HCoV-OC43,
HCoV-HKU1, MERS, SARS-CoV, and SARS-CoV-2).4,5
Within the betacoronavirus genus, HCoV-OC43 and HCoV-
HKU1 generally cause only a mild illness; in contrast, infec-
tion with MERS-CoV, SARS-CoV, and SARS-CoV-2 results
in a severe respiratory disease in some patients, with signifi-
cantly increased fatality rates.
Received: 9 September 2021 Revised: 28 October 2021 Accepted: 28 October 2021
DOI: 10.1002/pro.4220
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
© 2021 The Authors. Protein Science published by Wiley Periodicals LLC on behalf of The Protein Society.
Protein Science. 2021;1–12. wileyonlinelibrary.com/journal/pro 1
SARS-CoV-2 is most closely related to SARS-like cor-
onaviruses isolated from horseshoe bats found in South-
east Asia; it shares 79% of its sequence with SARS-CoV
and  50% with MERS-CoV. Since its initial identifica-
tion and characterization,6,7 genomic sequencing has
shown that the SARS-CoV-2 genome encodes—from its
50 to the 30 end—two large polyproteins 1a and 1ab that
are cleaved by viral proteases to generate 16 nonstructural
proteins (nsp1–nsp16), four structural proteins (S, E, M,
and N), and a number of other accessory proteins.
Upon viral infection, the host cell mounts a rapid
response of its innate immune system via the interferon
(IFN) pathway, resulting in the secretion of type-I and
type-III IFNs and subsequent activation of a signaling
pathway that leads to the expression of a wide range of
IFN-stimulated genes.8 A hallmark of COVID-19 is the
attenuation of the IFN response of the host coupled to
high levels of inflammatory cytokine production.9 SARS-
CoV-2 deploys multiple mechanisms to suppress the
innate immune response, with participation of several
viral proteins including nsp1, nsp6, nsp13, M, ORF3a,
ORF6, and ORF7a/b.10,11
The nsp1 protein is present in α- and β-coronaviruses
but not in γ- or δ-coronaviruses. nsp1 is a major virulence
factor for SARS and MERS, due its pleiotropic activities as
potent antagonist of virus- and IFN-dependent signaling
and suppressor of host mRNA translation.12–15 While there
is poor sequence conservation between the nsp1 proteins
from α- and β-coronaviruses, both have been shown to
induce strong suppression of host gene expression, albeit
possibly by different mechanisms.16–19 Despite poor
sequence identity, α-CoV nsp1 and β-CoV nsp1 share
structural homology in their core domain, which folds in a
6-stranded β-barrel structure with one α-helix on the rim
of the barrel.20–24 The importance and role of nsp1's globu-
lar domain are not yet fully understood, although it has
recently been shown to interact with the 5 0-UTR of the
SARS-CoV-2 mRNA, helping it escape translational inhibi-
tion in infected cells.25 In addition to their globular
domain, SARS-CoV and SARS-CoV-2 nsp1 proteins con-
tain a long, unstructured C-terminal extension. A two-
helix hairpin motif near the end of the C-terminal tail of
SARS-CoV-2 nsp1 has been shown to bind the 40S subunit
of the ribosome and block the mRNA entry channel, pro-
viding a structural basis for the role of nsp1 in suppressing
host translation in infected cells.16,26–28
Recently published studies of the human proteins
targeted by SARS-CoV-2 reported a physical association
between nsp1 and the primosome,29,30 the complex of
DNA polymerase α (Pol α) and primase responsible for
initiating DNA synthesis in DNA replication.31 In addi-
tion to its well-characterized nuclear role in genomic
duplication, participation of Pol α in innate immunity
has been suggested, based on the observation that
disease-associated mis-splicing of POLA1—coding for the
catalytic subunit of Pol α—results in abnormal IFN I
response and autoinflammatory manifestations.32–34
Here, we demonstrate that nsp1 binds directly to the cat-
alytic subunit of Pol α and elucidate their mode of inter-
action by determining the cryo-electron microscopy
(cryo-EM) structure of SARS-CoV nsp1 bound to the
human primosome. Our biochemical and structural char-
acterization of the interaction between the virulence fac-
tor nsp1 and the primosome suggests that targeting Pol
α–primase is part of a novel mechanism driving the
SARS-CoV-2 infection. Our data further define protein
epitopes on nsp1 and Pol α catalytic subunit that could
be exploited for the development of small-molecule
inhibitors of their interaction.
2 | RESULTS
2.1 | Biochemical analysis of nsp1
binding to the primosome
A proteomic screen of human proteins that interact with
SARS-CoV-2 proteins first reported the Pol α–primase
complex as high-confidence interactor of SARS-CoV-2
nsp1.29 A subsequent study expanded this approach to
include the SARS-CoV and MERS proteins and identified
the primosome as interactor of the related SARS-CoV
nsp1.30 Recently, a further interactome study between
viral and host proteins identified the primosome as a
high-confidence target of the SARS-CoV-2 nsp1.35 As
viral–host protein–protein interactions can play essential
roles in driving the infection, we sought to confirm the
reported interaction using purified, recombinant samples
of nsp1 and the primosome.
Maltose-binding protein (MBP)-tagged SARS-CoV-2
and SARS-CoV nsp1 were able to pull down both full-
length and truncated forms of purified primosome
(Figure 1a). The truncated primosome lacks the flexible
and largely unstructured N-terminal regions of both Pol
α (amino acids 1–333) and B subunit (amino acids 1–148)
that are known to mediate several primosome
interactions,36–39 thus indicating that the interaction with
nsp1 is not dependent on known recognition motifs in
Pol α and the B subunit. MERS nsp1 was also able to bind
to the primosome, albeit more weakly than the SARS
nsp1 proteins (Figure 1b), in accordance with the
proteome-wide interaction studies that identified the
primosome as a binding SARS-CoV and SARS-CoV-2
nsp1, but not MERS nsp1.30 Importantly, nsp1 from
human-infective coronavirus strains 229E, NL63, and
HKU1 did not interact with the primosome in our pull-
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down assay (Figure 1c). Thus, the affinity of nsp1 toward
Pol α correlates with the ability of the coronavirus strain
to cause serious disease.
In the original interaction study,29 nsp1 was
coprecipitated with all four subunits of Pol α–primase,
which are normally found associated as a constitutive
complex in the cell. To dissect the interaction between
primosome components and SARS-CoV-2 nsp1, we per-
formed a pull-down experiment using MBP-tagged nsp1
and the primase heterodimer Pri1–Pri2 (Figure 2a). We
detected no interaction between nsp1 and primase which,
taken together with the data presented in Figure 1a,
FIGURE 1 Biochemical
reconstitution of the primosome–
nsp1 interaction. The panels
report the result of pull-down
experiments on amylose beads of
human primosome by the
indicated nsp1 proteins, N-
terminally fused to maltose-
binding protein (MBP), analyzed
by SDS-PAGE. The lane marked
with a dash symbol is the negative
control for pull-down by MBP
only. (a) Pull-down of full-length
and truncated primosomes. A
schematic drawing of subunit size
for full-length and truncated
primosomes is shown above the
panels; (b) pull-down of truncated
primosome with SARS-CoV,
SARS-CoV-2, and MERS nsp1;
(c) pull-down of truncated
primosome with SARS-CoV,
NLS63, 229E, and HKU1 nsp1.
Bands labeled with an asterisk
indicate free His6-MBP. nsp1,
Nonstructural protein 1; Pol α,
DNA polymerase α; SDS-PAGE,
sodium dodecyl sulfate–
polyacrylamide gel electrophoresis
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FIGURE 2 Biochemical dissection of the primosome–nsp1 interaction. The panels report the result of pull-down experiments on
amylose beads of human primosome by the indicated nsp1 proteins, N-terminally fused to maltose-binding protein (MBP), analyzed by SDS-
PAGE. The lane marked with a dash symbol is the negative control for pull-down by MBP only. (a) Pull-down of truncated primosome and
primase; (b) pull-down of truncated primosome by N-, M-, and C-terminal domains of SARS-CoV and SARS-CoV-2 nsp1 proteins. On the
right, schematic diagram of the domain structure of nsp1; (c) pull-down of truncated primosome by SARS-CoV-2 wild-type and single-point
mutant L27D, V28D, and V111D nsp1 proteins. nsp1, Nonstructural protein 1; Pol α, DNA polymerase α; SDS-PAGE, sodium dodecyl
sulfate–polyacrylamide gel electrophoresis
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indicates that the nsp1-binding site resides within the
folded domains of Pol α and the B subunit.
Next, we sought to define the region of nsp1 responsi-
ble for the interaction with the primosome. SARS-CoV
and SARS-CoV-2 nsp1 fold into a globular middle
domain (M; amino acids 13–127) flanked by a short N-
terminal region (N; amino acids 1–12) and a long C-
terminal extension that is predicted to be largely unstruc-
tured (C; amino acids 128–180). Pull-down experiments
with the N, M, and C regions of SARS nsp1 showed
clearly that the middle domain is responsible for the
interaction with the primosome (Figure 2b).
Guided by the published crystal structures of
nsp1,20,23,24 we identified an exposed hydrophobic surface
centered around amino acids L27 and V28 in the first
interstrand loop of the β-barrel in the middle domain and
V111 in the last interstrand loop, as a possible
primosome-binding epitope. Point mutations to
aspartate—that reversed the chemical nature of the side
chain—weakened (L27D) or abolished (V28D and
V111D) the interaction of the MBP-tagged nsp1 mutants
with the primosome in our pull-down assay (Figure 2c),
thus implicating these residues in the interaction.
2.2 | Cryo-EM structure of the
primosome–nsp1 complex
Our findings had shown that a direct biochemical inter-
action exists between nsp1 and the primosome, con-
firming the result of the proteomic screens.29,30 We
therefore decided to elucidate the structural basis for the
interaction by determining the high-resolution structure
of the primosome–nsp1 complex by cryo-EM (Figure S1–
S3, Table S1). SARS-CoV nsp1 was chosen for the struc-
tural analysis as this variant showed somewhat stronger
binding to human primosome in our pull-down assays
(Figure 1a). We note that there is a high degree of
sequence conservation between SARS-CoV and SARS-
CoV-2 nsp1 (84.4 and 85.8% identity over the entire
sequence and the middle domain only, respectively).
We obtained a 3D reconstruction of the primosome at a
global resolution of 3.8 Å after sharpening that clearly
showed all components of the complex (Figures S4 and S5).
As the portion of the map relative to the primase
subunit Pri1 was weaker, a new map was calculated using
subtracted particles from which Pri1 had been omitted,
yielding a slightly improved map at a global resolution of
3.6 Å after sharpening. Both maps—from full and subtracted
particles—were used during model building. Density
belonging to the nsp1 middle domain was clearly visible at a
lower map threshold than required to visualize the
primosome core.
The cryo-EM structure of the human primosome con-
firmed the presence of the binary interfaces that had
been previously defined by X-ray crystallography of yeast
and human Pol α–primase subcomplexes.40–44 Intrigu-
ingly, our cryo-EM analysis of the primosome revealed a
quaternary structure that is incompatible with known
and presumed conformations required for activity by its
two catalytic subunits, Pol α and primase42,45–47
(Figure 3). Thus, the B subunit bound to the C-terminal
domain of Pol α is docked within the open “hand”
of the polymerase domain, precluding binding of the
template DNA–primer RNA duplex. Furthermore, the
heterodimeric primase is held in an extended conforma-
tion, whereby the Fe-S domain of Pri2—required for ini-
tiation of RNA primer synthesis48—is sequestered by
interactions with both B and Pol α and unavailable to
contact Pri1, which is excluded from the primosome core
and largely solvent exposed.
Overall, the cryo-EM structure is highly similar to a
structure of the human primosome determined earlier by
X-ray crystallography49 (Figure S6). Although reasonable
doubts existed that the crystal structure might have been
a crystallization artifact, these have now been dispelled
by our cryo-EM analysis. Altogether, the high-resolution
structural data obtained with X-ray and cryo-EM
methods indicate that—in its unliganded form—the
human primosome exists in a conformation that is
incompatible with primer synthesis without the interven-
tion of major conformational rearrangements. Why
should the primosome adopt such a distinct quaternary
structure in the absence of its DNA and nucleotide sub-
strates and what should be the function of this postulated
autoinhibited state49 remain unclear.
The structure shows that nsp1 binds to the Pol α sub-
unit of the primosome (Figure 4). The globular domain of
nsp1 docks onto the rim of the polymerase fold of Pol α,
and its binding site is entirely contained within the inac-
tive exonuclease domain of the polymerase, in agreement
with our biochemical findings (Figures 1 and 2). Nsp1
binding is mediated by residues in the first, second, and
fourth interstrand loop of the globular β-barrel domain
and in the α-helix at the C-end of the second interstrand
loop. The interface is of a mixed hydrophobic and polar
nature (Figure 5). A cluster of hydrophobic nsp1 residues
at the center of the interface—including L27, V28, P109,
V111, and G112—becomes buried upon complex forma-
tion (Figures 5a and S7), validating the observation that
mutations of nsp1 residues V28 and V111 abrogate the
interaction (Figure 2c).
The nsp1-binding area in Pol α is centered on the sec-
ond α-helix of the exonuclease domain, comprising resi-
dues 615 to 629 (recognition helix), and extends to include
solvent-exposed amino acids flanking the recognition helix,
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from V585 to I662 (Figures 5b and S7). Hydrophobic amino
acids in the exonuclease domain that match the hydropho-
bic surface of nsp1 in the complex are helical residues
A624, G620, and F621, the short aliphatic segment
611-VAAT-614 in the loop leading into the recognition
helix, and P657 toward the C-end of the binding interface.
The interaction shows pronounced charge comple-
mentarity (Figures 5a,b and S7). A cluster of negatively
charged residue in nsp1—D33, E36, E37, E41, and E44 in
the helix of the second intrastrand loop, as well as D25,
E65, and E113—lines the edge of the interaction area and
becomes juxtaposed upon complexation to basic residues
K625, K628, and R616 in the recognition helix of the exo-
nuclease domain of Pol α, as well as to surrounding
lysine residues K588, K590, K599, K655, and K661.
The presence at the interface of small amino acids such
as alanine and glycine, that are required for the intimate
FIGURE 3 Cryo-EM structure of the primosome–nsp1
complex. The structure is drawn as a cartoon with helices as solid
cylinders and strands as arrows. Each subunit is labeled and
uniquely colored, in orange (Pol α), red (B subunit), lilac (Pri1),
purple (Pri2), and pink (nsp1). The structure is shown in two views,
from the side (top panel) and from the top (bottom panel). Cryo-
EM, cryo-electron microscopy; nsp1, nonstructural protein 1; Pol α,
DNA polymerase α
FIGURE 4 nsp1 binds to the exonuclease domain of Pol α.
(a) Space-fill representation of the interaction between nsp1 (pink)
and the inactive exonuclease domain of Pol α (orange) and (b) two
views rotated by 90 of the association mode of nsp1 with the
exonuclease domain. The proteins are drawn as ribbons in pink
(nsp1) and orange (Pol α). A disordered loop of nsp1 facing away
from the interface is shown as a dotted line. The position of the
recognition helix in the exonuclease domain is indicated. nsp1,
Nonstructural protein 1; Pol α, DNA polymerase α
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association of rather flat protein surfaces, supports the
observed interaction between nsp1 and Pol α. Notably, the
nsp1-binding sequence 611-VAAT-614, as well as the
620-GFxxA-624 motif in the recognition helix, are highly
conserved in vertebrate Pol α sequences (Figure S7).
3 | DISCUSSION
Here, we have provided a biochemical and structural
basis for the interaction between the SARS-CoV-2
virulence factor nsp1 and the primosome, for which evi-
dence first emerged from protein–protein interaction
screens between SARS-CoV-2 and human proteins. Our
structure shows that nsp1 uses its globular domain to
interact with the primosome, distinct from the C-
terminal motif employed to target the ribosome and sup-
press mRNA translation. Thus, our findings provide the
first structural evidence of how nsp1 can deploy its con-
served middle domain to engage with a host protein.
The ability of nsp1 to use different regions of its
sequence to target different physiological processes in the
FIGURE 5 The nsp1–Pol α exonuclease domain interface. (a) On the left, a space-fill model of nsp1, with interface residues labeled and
colored in pink. On the right, the charge distribution of nsp1 mapped over its molecular surface (red: negative charge; blue: positive charge);
(b) on the left, a space-fill model of the exonuclease domain of Pol α, with interface residues labeled and colored in orange, and on the right,
the charge distribution of the exonuclease domain mapped over its molecular surface (red: negative charge; blue: positive charge). nsp1,
Nonstructural protein 1; Pol α, DNA polymerase α
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cell is in keeping with evidence of its pleiotropic patho-
logical effects during infection. Furthermore, as viral pro-
teins are known to exploit existing binding epitopes on
the surface of the target protein, the nsp1-binding site in
Pol α might be indicative of as yet unknown physiological
partners of the primosome binding at this site. The dis-
covery of a novel protein–protein interaction surface in
nsp1 and Pol α opens up the possibility of developing
small-molecule inhibitors aimed at disrupting their asso-
ciation, which might be of therapeutical value in the
treatment of COVID-19.
How the interaction of nsp1 with the primosome
might promote virulence is currently unclear. However, a
rationale for targeting the primosome by SARS-CoV-2
might be envisaged based on recent evidence that muta-
tions in POLA1—coding for the catalytic subunit of Pol
α—cause X-linked reticulate pigmentary disorder
(XLPDR), a genetic syndrome that is characterized by
activation of type I IFN signaling, a persistent inflamma-
tory state and recurrent lung infections.32,33 A similar set
of symptoms is observed in individuals with inherited
haploinsufficiency of the PRIM1 gene, coding for the Pri1
subunit of primase.50 In XLPDR fibroblasts, the ability of
Pol α–primase to synthesize RNA/DNA hybrids in the
cytoplasm was found to be impaired.32 This effect was
proposed to be responsible for the disease, although the
molecular mechanisms by which cytosolic RNA/DNA
hybrids might help regulate the antiviral response are
unknown.
To test whether nsp1 binding may directly affect the
enzymatic activity of the primosome, we performed bio-
chemical assays to measure the RNA and DNA primer
synthesis activities of primase and Pol α, respectively.
However, we could not detect an effect on RNA primer
synthesis or DNA extension in the presence of an excess
of nsp1 protein (Figure S8). This is consistent with the
3D structure of the primosome–nsp1 complex, in which
nsp1 is docked in a position that is not expected to inter-
fere with RNA–DNA primer synthesis.
Given the exclusively cytoplasmic localization of
SARS and MERS nsp1 upon infection,30 the interaction
with nsp1 appears aimed at targeting the primosome frac-
tion present in the cytoplasm of infected cells. As nsp1
binding did not seem to impact the enzymatic activity of
the primosome, we speculate that any effect on
primosome activity might be achieved indirectly. Thus,
nsp1 binding might be necessary for recruitment of addi-
tional factors that inhibit primosome activity or sequester
it in a way that makes it inactive; alternatively, nsp1
binding might target the primosome for ubiquitination
and degradation (Figure 6). Further study will be
required to establish how primosome targeting by SARS-
CoV-2 affects the antiviral response of the host cell.
4 | MATERIALS AND METHODS
4.1 | Cloning, expression, and protein
purification
Full-length human primosome (Pol α: 1–1,462; B subunit:
1–598; PriS: 1–420; PriL: 1–509) and truncated human
primosome (Pol α: 334–1,462; B subunit: 149–598; PriS:
1–420; PriL: 1–509) were expressed in Sf9 insect cells and
purified as described previously.38 Full-length coronavi-
rus nsp1 genes (SARS-CoV-2, SARS-CoV, MERS, HKU1,
NL63, and 229E) were ordered as synthetic gBlocks (IDT)
and cloned into bacterial expression vector pMAT11.51
nsp1 proteins were expressed as His6-MBP-tagged fusion
proteins from the Rosetta2 (DE3) Escherichia coli strain
(Novagen). nsp1 fragments (SARS-CoV N-terminus [1–
12], middle domain [13–127], and C-terminus [128–180];
SARS-CoV-2 N-terminus [1–12], middle domain [13–
127], and C-terminus [128–180]) were cloned and
expressed in the same way. Full-length SARS-CoV-2 nsp1
point mutants (V111D, L27D, and V28D) were ordered as
synthetic gBlocks (IDT) and cloned and expressed as
above.
All His6-MBP-fusion proteins were purified by metal
affinity chromatography using Ni-NTA agarose (Qiagen).
A high-salt wash (500 mM KCl) was performed on-
column to remove any traces of nucleic acid from the
protein preparation. Proteins were eluted using 25 mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) pH 7.2, 300 mM KCl, and 200 mM imidazole.
4.2 | Cryo-EM sample preparation and
grid freezing
SARS-CoV His6-MBP-nsp1 (13–127) was TEV-cleaved
overnight at 4C, and the His6-MBP tag was subsequently
recaptured using amylose resin (NEB). The flow-through
was loaded onto a Q-HP anion exchange column (Cytiva)
and eluted with a KCl gradient (25 mM HEPES pH 7.2,
80–750 mM KCl, and 2 mM Dithiothreitol [DTT]). Nsp1
and the truncated primosome were subsequently individ-
ually buffer-exchanged into cryo-EM buffer (25 mM
HEPES pH 7.2, 150 mM KCl, and 1 mM DTT) using a
NAP5 column (Cytiva). The two proteins were mixed at
final concentrations of 1 μM primosome and 10 μM nsp1.
1 mM BS3 cross-linker was added, and the sample was
incubated on ice before grid freezing using a Vitrobot set
at blot force 10 (Thermo Fisher Scientific). The samples
were diluted 1:2 with cryo-EM buffer immediately before
the application of the protein sample to the grid; 3 μl
sample was applied to each side of the UltrAuFoil grid
(300 mesh, R 1.2/1.3, Quantifoil), which had been glow
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discharged on both sides (25 mA, 1 min each side). The
grids used for the eventual structure determination were
plunge frozen in liquid ethane approximately 45 min
after the addition of the BS3 cross-linker.
4.3 | Cryo-EM data processing and
structure refinement
Data collection parameters, structure refinement details,
and statistics are reported in Table S1 and Figure S1;
393 movies (1.11 e/Å2/fraction, 40 fractions) were
collected on a Talos Arctica at 200 keV, 92,000 magnifi-
cation, and 1.13 px/Å, with a Falcon III detector in cou-
nting mode. Movie processing was carried out in Relion
3.1.52 The movies were motion corrected using Relion's
implementation and CTFs were estimated using
CTFFIND4-1.53 An initial set of 165,011 particles was
auto-picked and used to generate 2D templates for
template-based picking of a new set of 183,301 particles.
The template-picked particle set was reduced to 97,680
particles by rounds of 2D classification and used to recon-
struct an initial 3D volume. 3D classification into four
models generated one model with 47,542 particles
FIGURE 6 Possible functional significance of primosome targeting by SARS-CoV-2 nsp1. (a) In addition to its well-established role in
chromosomal DNA duplication during S-phase, a cytoplasmic role for Pol α–primase has been postulated to synthesize RNA/DNA duplexes
that might mediate the interferon response32; (b) speculative modes of action of nsp1-dependent SARS-CoV-2 interference with cytoplasmic
Pol α–primase. nsp1, Nonstructural protein 1; Pol α, DNA polymerase α
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(48.6%) which was refined to 7.29 Å. The 3D volume
showed clear evidence of the four primosome subunits
and of the bound nsp1 protein; the initial 3D model was
used as starting point for 3D classification during
processing of the higher resolution data set.
A total of 2,919 movies (0.98 e/Å2/fraction, 48 frac-
tions) were collected on Titan Krios at 300 keV, 130,000
magnification, and 0.326 Å px/Å with a K3 detector in
super-resolution counting mode. Movie processing was
carried out in Relion 3.1.52 The movies were motion
corrected and 2 binned using Relion's own implementa-
tion, and CTFs were estimated using CTFFIND4-1.53 An
initial set of 314,987 particles was auto-picked and
improved by rounds of 2D classification, to generate 2D
templates for template-based picking of a new set of
709,068 particles. The particle set was improved by multi-
ple rounds of selection by 2D classification, and a first 3D
classification into four models was performed using the
initial 3D model obtained for the Talos data set. Class #1
(251,901 particles) was selected and a second round of 3D
classification was performed, leading to a new 3D Class
#4 with 233,476 particles. 3D refinement of this class
yielded a map at 4.12 Å, which was sharpened in Phe-
nix54 using “phenix.local_aniso_sharpen” to a resolution
of 3.8 Å (0.143 FSC) and used for model interpretation
and model building.
For model building, the crystal structure of human
Pol α–primase (PDB ID 5EXR) was fitted manually in the
map with ChimeraX55 and real-space refined in Phenix,54
together with local manual rebuilding in Coot.56 Addi-
tional density corresponding to the known structure of
nsp1 was clearly detectable, although at a lower map
threshold, bound to Pol α. A model of SARS nsp1 was
built based on PDB entries 7K3N and 2HSX and docked
into the map in ChimeraX.55 The Pol α–primase–nsp1
complex was further real-space refined in Phenix.54
Inspection of the 2D/3D classes and of the 3D refined
map for the Pol α–primase–nsp1 complex showed that
the density corresponding to the Pri1 subunit of primase
was weaker. This observation was explained by the looser
contact of Pri1 with the rest of the Pol α–primase, which
is primarily mediated by the known interface with
Pri242. To improve the map of the rest of Pol α–primase
and of the bound nsp1, a mask was prepared in
ChimeraX55 that excluded the Pri1 lobe and used to gen-
erate a set of subtracted particles from the 233,476 parti-
cles set used to generate the original 3D refined map. A
new initial 3D model was first generated, and after a
round of 3D classification, Class #3 (103,763 particles)
was selected. 3D refinement of this class generated a
4.40 Å map, that was sharpened using “phenix.
local_aniso_sharpen” to a resolution of 3.6 Å (01.43 FSC)
and used for model interpretation and model building.
The map showed slightly better high-resolution features
for the primosome core and clearer features for the nsp1
fold and was therefore used as a visual aid in the refine-
ment of the primosome–nsp1 complex structure.
4.4 | Pull-downs
A total of 150 μl amylose resin (NEB) was equilibrated in
pull-down buffer (1 phosphate-buffered saline, 5% glyc-
erol, 0.1% Igepal CA-630, and 1 mM tris(2-carboxyethyl)
phosphine or DTT). An excess of His6-MBP-nsp1 was
added to saturate the beads with bait protein. The His6
-MBP tag protein was used as negative control. Beads were
washed twice with pull-down buffer to remove excess,
unbound bait protein. BSA was added to a final concentra-
tion of 2.5 mg/ml1. Primosome (full length or truncated)
was added to the beads, which were subsequently incu-
bated at 4C for 1 hr with rolling. The beads were washed
four times with 1 ml pull-down buffer. Bound protein was
eluted using 150 μl pull-down buffer supplemented with
50 mM maltose. Samples were analyzed by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis.
4.5 | Primosome activity assay
Full-length His6-MBP-nsp1 (from SARS-CoV-2 and
SARS-CoV) was TEV-cleaved overnight at 4C. The His6
-MBP tag was recaptured using amylose resin (NEB). The
flow-through was loaded onto a Q-HP anion exchange
column (Cytiva), and nsp1 was eluted with a KCl gradi-
ent (25 mM HEPES pH 7.2, 80–750 mM KCl, and 2 mM
DTT). Pure nsp1 was subsequently buffer exchanged into
25 mM HEPES pH 7.2, 100 mM KCl, and 1 mM DTT
using a NAP5 column (Cytiva).
An activity assay, to monitor the ability of Pol α to
extend an RNA primer, was performed using a pre-
annealed DNA–RNA template (DNA45: 50- TTCTTT
ATCTCTTATTTCCTTCTATTTTCCACGCGCCTTCTAT
TT-30; RNA13: 50-[6FAM]-GGCGCGUGGAAAA-30,
Sigma Aldrich). The reaction buffer comprised 25 mM
HEPES pH 7.2, 100 mM KCl, 10 mM Mg(OAc)2, and
1 mM DTT. Each 100 μl reaction contained 2 μM DNA–
RNA template, 1 mM dNTP, 10 μM nsp1, and 0.1 μM
full-length primosome. Reactions were incubated at
25C, and 30-μl aliquots were removed and quenched
(by adding an equal volume of 95% formamide and
25 mM EDTA) at the indicated time points. Samples were
heated to 70C for 2 min, then loaded onto a 19% urea-
polyacrylamide gel (running conditions: 450 V, 90 min,
0.5 TBE buffer). Gels were initially imaged by laser
scanning (473 nm laser, Typhoon FLA 9000, GE
10 KILKENNY ET AL.
Healthcare), to detect only the 6FAM-labeled products.
Gels were subsequently stained using a 1:10000 dilution
of SYBR Gold Stain (Thermo Fisher Scientific) in 0.5
TBE buffer and reimaged in the same way to detect all
nucleic acid.
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